XML 195 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity - Summary of Company's Restricted Share Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Beginning balance (in shares) 397  
Granted (in shares) 0  
Exercised (in shares) (30)  
Canceled/forfeited (in shares) (3)  
Expired (in shares) (46)  
Ending balance (in shares) 318 397
Exercisable (in shares) 298  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Weighted average exercise price, beginning balance (in dollars per share) $ 2.89  
Weighted average exercise price, granted (in dollars per share) 0  
Weighted average exercise price, exercised (in dollars per share) 1.71  
Weighted average exercise price, canceled/forfeited (in dollars per share) 2.24  
Weighted average exercise price, expired (in dollars per share) 4.48  
Weighted average exercise price, ending balance (in dollars per share) 2.78 $ 2.89
Weighted average exercise price, exercisable (in dollars per share) $ 2.78  
Weighted-average remaining contractual term, outstanding 5 years 7 months 6 days 5 years 8 months 12 days
Weighted-average remaining contractual term, exercisable 4 years 8 months 12 days  
Aggregate intrinsic value outstanding $ 1,122 $ 998
Aggregate intrinsic value exercisable $ 1,054